During the XXII Russian Oncological Congress professor of Sechenov Medical University, Head of Personalized Oncology Center “OncoTarget”, Marina Sekacheva, presented the results of a proof-of-concept ARNA Breast Cancer test.
Results of an open controlled monocentric study on 27 blood samples of patients the test have shown the sensitivity of 100% (0 false negatives) and the specificity of 91% (1 false positive out of 11).
Such impressive results of the study, according to experts, are the basis for conducting a blind controlled study and, if such unique high statistical test parameters are confirmed, for registration of the test and its implementation in breast cancer screening practice.
The presentation video is available below (Russian only):
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.